|
|
Πνευμονολογία - Φυματολογία |
Esbriet |
Μη παρεμβατική μελέτη με φάρμακο |
Roche Hellas |
A MULTICENTER, POST-MARKETING, NON-INTERVENTIONAL, OBSERVATIONAL STUDY TO EVALUATE QUALITY OF LIFE IN PATIENTS IN GREECE WITH IDIOPATHIC PULMONARY FIBROSIS UNDER TREATMENT WITH PIRFENIDONE |
PNEUMON |
εμφάνιση |
|
|
Ακτινοθεραπευτική - Ογκολογία |
nab-paclitaxel |
Μη παρεμβατική μελέτη με φάρμακο |
Genesis Pharma |
A multicenter, prospective cohort study to provide real-world evidence on the effect of ABRAXANE® treatment on the clinical outcomes and health-related quality of life in patients with metastatic breast Cancer in Greece. |
ABReast |
εμφάνιση |
|
|
Οφθαλμολογία |
|
Μη παρεμβατική μελέτη χωρίς φάρμακο (επιδημιολογική) |
Roche Hellas |
A MULTICENTER, PROSPECTIVE EPIDEMIOLOGIC STUDY OF THE PROGRESSION OF GEOGRAPHIC ATROPHY SECONDARY TO AGE−RELATED MACULAR DEGENERATION |
PROXIMA-A |
εμφάνιση |
|
|
Ακτινοθεραπευτική - Ογκολογία |
trabectedin |
Μη παρεμβατική μελέτη με φάρμακο |
Genesis Pharma |
A Multicenter, Prospective, Observational Study to Assess the Clinical ActivitYand the Impact in SymptOm Burden and PatieNts’HRQoL of Treatment with TrabecteDin in advanced Soft Tissue Sarcomas in a Real World Setting in Greece. |
BeYOND STS |
εμφάνιση |
|
|
Αιματολογία |
Gazyvaro |
Μη παρεμβατική μελέτη με φάρμακο |
Roche Hellas |
A MULTICENTER, SINGLE ARM, NONINTERVENTIONAL,
OBSERVATIONAL STUDY OF
OBINUTUZUMAB TO EVALUATE EFFICACY,
SAFETY AND COST OF DISEASE MANAGEMENT
IN PATIENTS WITH CHRONIC LYMPHOCYTIC
LEUKEMIA AND COMORBIDITIES IN GREECE |
GAEA |
εμφάνιση |
|
|
Ακτινοθεραπευτική - Ογκολογία |
GIOTRIF |
Μη παρεμβατική μελέτη με φάρμακο |
Boehringer Ingelheim Ellas A.E. |
A multicentre, cohort study to assess the impact on
SYMptom burden and patient health-related quality of Life
of afatinib treatment in advanced non-small cell lung cancer
in a real world setting in Greece. The ‘SYM-Less’ study |
SYMLess |
εμφάνιση |
|
|
Νεφρολογία |
LOKELMA |
Μη παρεμβατική μελέτη με φάρμακο |
Astrazeneca |
A national, multicenter, prospective, observational Study to assess patient characteristics, treatment algorithms and disease management of Hyperkalaemia patients with chronic kIdney disease or under dialysis or with hEart faiLure, treated with soDium zirconium cyclosilicate in Greece |
SHIELD |
εμφάνιση |
|
|
Ακτινοθεραπευτική - Ογκολογία |
|
Μη παρεμβατική μελέτη χωρίς φάρμακο (επιδημιολογική) |
MSD |
A nationwide retrospective observational study to record patient characteristics and treatment patterns in a representative sample of patients with earlier stages of Non-Small Cell Lung Cancer (NSCLC), as well as to capture the distribution of disease stages and the systemic treatment rate among patients diagnosed with NSCLC of any stage during the period 2016-2020 in Greece.
|
INFINITY |
εμφάνιση |
|
|
Αιματολογία |
|
Μη παρεμβατική μελέτη χωρίς φάρμακο (επιδημιολογική) |
Genesis Pharma |
A Nationwide, Epidemiological, Retrospective Cross-Sectional Study to Capture the Real-World Complication BUrden, Associated Hospital Resource UtiLization, and Disease Management Paradigms and to IdentifY Determinants of Complications in Transfusion-Dependent Beta-ThalaSSEmia AdultS in Greece.
The “ULYSSES” Study
|
ULYSSES |
εμφάνιση |
|
|
Δερματολογία - Αφροδισιολογία |
HUMIRA |
Μη παρεμβατική μελέτη με φάρμακο |
AbbVie Φαρμακευτική Α.Ε. |
A non-interventional prospective cohort study to provide real-world evidence on the treatment goal achievement rate, adherence to and utilization patterns of adalimumab in patients with moderate to severe plaque psoriasis in Greece. |
CONCORDIA |
εμφάνιση |
